Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

Rhea-AI Summary

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on intelligent, rapid, non-invasive testing solutions, has announced its participation in the upcoming iAccess Alpha Virtual Best Ideas Spring Conference 2025.

The conference is scheduled for March 25-26, 2025, with INBS management's presentation set for Tuesday, March 25th at 11:00 a.m. ET. The presentation will be accessible via webcast. Additionally, the company will conduct one-on-one meetings during the conference, which interested parties can schedule through iAccess representatives or by contacting KCSA Strategic Communications.

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the iAccess Alpha Virtual Best Ideas Spring Conference 2025 on March 25 and 26, 2025.

iAccess Alpha Virtual Conference Details:
Date: March 25-26, 2025
Presentation Day and Time: Tuesday, March 25^th at 11:00 a.m. ET
Webcast: https://www.webcaster4.com/Webcast/Page/3083/52118

INBS will also conduct one-on-one meetings during the conference. To schedule a meeting with management, please contact your representatives at iAccess or email KCSA Strategic Communications at INBS@KCSA.com.

About Intelligent Bio Solutions Inc. 

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

For more information, visit: http://www.ibs.inc/

Company Contact:   
Intelligent Bio Solutions Inc.  
info@ibs.inc   
LinkedIn | Twitter 

Investor & Media Contact:  
Valter Pinto, Managing Director  
KCSA Strategic Communications  
PH: (212) 896-1254  
INBS@kcsa.com

FAQ

When is Intelligent Bio Solutions (INBS) presenting at the iAccess Alpha Conference 2025?

INBS is presenting on Tuesday, March 25th, 2025 at 11:00 a.m. ET during the iAccess Alpha Virtual Best Ideas Spring Conference.

How can investors attend the INBS presentation at the iAccess Conference?

Investors can access the presentation through the webcast link: https://www.webcaster4.com/Webcast/Page/3083/52118

What type of meetings is INBS offering during the iAccess Conference 2025?

INBS is offering one-on-one meetings with management during the conference, which can be scheduled through iAccess representatives or KCSA Strategic Communications.

What is the main business focus of INBS according to the conference announcement?

INBS is a medical technology company that develops and delivers intelligent, rapid, non-invasive testing solutions.